טוען...
Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design
The quest for an effective HIV-1 vaccine began as soon as the virus causing AIDS was identified. After several disappointing attempts, results of the Phase-III RV144 trial in Thailand were a beacon of hope for the field demonstrating correlation between protection and immunological markers. In order...
שמור ב:
| הוצא לאור ב: | AIDS Res Ther |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5594512/ https://ncbi.nlm.nih.gov/pubmed/28893288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12981-017-0164-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|